Chidamide
-
Catalog number2261-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_nameN-(2-amino-5-fluorophenyl)-4-[[[1-oxo-3-(3-pyridinyl)-2-propen-1-yl]amino]methyl]-benzamide
-
DescriptionCell-permeable. A new benzamide class of histone deacetylase (HDAC) inhibitor with marked anti-tumor activity. It increases histone H3 acetylation levels in LoVo and HT29 colon cancer cells at concentrations as low as 4 µM. Additionally, chidamide affects the activation of oncogenic signaling kinases by dose-dependently reducing phosphorylated Akt, mTOR, p70S6k, Raf, and Erk1/2 protein expression in colon cancer cells.
-
CAS Number743420-02-2
-
Structure AvailableYes
-
Peptide sequenceNo
-
Salt FormNo
-
Molecular FormulaC₂₂H₁₉FN₄O₂
-
Molecular Weight390.41
-
Cell PermeableYes
-
Purity≥98%
-
SolubilitiesDMSO
-
HandlingProtect from light and mositure
-
Tag LineA potent histone deacetylase inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life24 months
-
PubChem CID53394037
-
SMILESC1=CC(=CN=C1)C=CC(=O)NCC2=CC=C(C=C2)C(=O)NC3=C(C=CC(=C3)F)N
-
InChiInChI=1S/C22H19FN4O2/c23-18-8-9-19(24)20(12-18)27-22(29)17-6-3-16(4-7-17)14-26-21(28)10-5-15-2-1-11-25-13-15/h1-13H,14,24H2,(H,26,28)(H,27,29)
-
InChi KeyWXHHICFWKXDFOW-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameChidamide
-
Alternative nameChidamide
-